Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations (Unaudited)

v3.25.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Income Statement [Abstract]        
Revenue, net $ 8,756 $ 12,295 $ 29,504 $ 34,515
Cost of revenue 3,317 4,393 11,418 12,496
Gross profit 5,439 7,902 18,086 22,019
Operating expenses:        
Sales and marketing 2,087 2,864 7,811 8,571
Research and development 150 199 500 483
General and administrative 2,057 2,538 7,268 6,918
Total operating expenses 4,294 5,601 15,579 15,972
Operating income from continuing operations 1,145 2,301 2,507 6,047
Interest accretion expense (4) (34)
Note payable interest (30) (141) (156) (514)
Other expense, net (115) (394) (112) (406)
Income from continuing operations before tax 1,000 1,762 2,239 5,093
(Benefit) provision for income taxes (11) 4 7 12
Income from continuing operations 1,011 1,758 2,232 5,081
Loss from discontinued operations, net of tax (100) (82) (314) (260)
Net income $ 911 $ 1,676 $ 1,918 $ 4,821
Basic income (loss) per share of common stock:        
From continuing operations $ 0.23 $ 0.40 $ 0.50 $ 1.16
From discontinued operations (0.02) (0.02) (0.07) (0.06)
Net income (loss) per basic share of common stock 0.21 0.38 0.43 1.10
Diluted income (loss) per share of common stock:        
From continuing operations 0.04 0.40 0.08 1.15
From discontinued operations (0.01) (0.02) (0.01) (0.06)
Net income (loss) per diluted share of common stock $ 0.03 $ 0.38 $ 0.07 $ 1.09
Weighted average number of common shares and common share equivalents outstanding:        
Basic 4,425 4,393 4,423 4,380
Diluted 27,695 4,423 27,693 4,404